An FBI investigation into the death of Colts owner Jim Irsay raises critical questions about prescription practices among addiction specialists.
Story Highlights
- The FBI is probing the death of Indianapolis Colts owner Jim Irsay, focusing on potential prescription drug issues.
- Dr. Harry Haroutunian, who treated Irsay, is under scrutiny for his prescribing practices.
- The investigation follows a pattern seen in high-profile cases like the Matthew Perry incident.
- The Colts organization has yet to receive subpoenas related to the investigation.
FBI Launches Investigation into Irsay’s Death
The FBI has initiated a federal investigation into the death of Indianapolis Colts owner Jim Irsay, who passed away in May 2025 at the Beverly Hills Hotel.
This probe centers on the role of Dr. Harry Haroutunian, an addiction specialist who prescribed substances including opioids and ketamine to Irsay and signed his death certificate. The absence of an autopsy and the circumstances of Irsay’s death have prompted federal scrutiny.
Federal authorities are examining whether there were any irregularities in the prescribing practices of Dr. Haroutunian. This investigation draws parallels to the 2023 case involving actor Matthew Perry, where a similar pattern of prescription practices led to federal charges. Irsay’s public history of substance abuse and the federal attention on prescription drugs add layers of complexity to the case.
Impact on the Colts and Irsay’s Legacy
The Indianapolis Colts, now owned by Irsay’s daughters, have acknowledged awareness of the investigation but report no direct involvement or subpoenas at this stage. The team’s leadership insists on transparency but remains focused on avoiding disruptions. The probe could lead to significant scrutiny of the Colts organization, affecting its operations and leadership if it progresses further.
Irsay’s legacy as a prominent NFL owner and his contributions to the league are under a shadow as the investigation unfolds. His leadership saw the Colts to a Super Bowl victory in 2007, yet his personal struggles with addiction were well-documented.
The ongoing investigation may impact the perception of his tenure and influence how addiction treatment practices are viewed within sports circles.
The FBI is investigating the death of former Colts owner Jim Irsay
The same doctor accused of supplying him with massive amounts of opioids and ketamine also signed the death certificate and ruled it a “natural” death per @washingtonpost pic.twitter.com/Eb9R8d4ekt
— Bussin' With The Boys (@BussinWTB) January 22, 2026
Broader Implications of the Investigation
The implications of this investigation extend beyond Jim Irsay and the Colts. It highlights the growing concerns over prescription practices in addiction treatment, particularly the use of substances like ketamine. The case could set precedents for how medical professionals are scrutinized and regulated concerning celebrity clients.
The NFL and other sports organizations may face increased pressure to ensure accountability among owners and executives.
Death of Indianapolis Colts owner Jim Irsay under federal investigation: Sources https://t.co/AcAsEZhKHp
— Action News on 6abc (@6abc) January 24, 2026
The outcome of this probe has the potential to alter the landscape of addiction treatment protocols and regulations, especially regarding off-label drug use. It underscores the need for vigilant oversight and transparency to prevent misuse and ensure patient safety.
As the investigation progresses, the focus will likely remain on upholding legal and ethical standards within the medical community.
Sources:
Colts confirm FBI investigating death of former owner Jim Irsay
Death of Indianapolis Colts owner Jim Irsay under federal investigation
